Codex DNA alternatives

Labs that want to keep synthesis in-house often evaluate Twist Bioscience’s DNA data-storage and synthesis services, Ginkgo Bioworks automated foundries, or GenScript’s gene synthesis platforms. Each differs in whether hardware sits inside the user’s lab or remains at a central facility.

Codex DNA charges for the BioXp instrument plus consumable kits; Twist bills per base or per construct shipped. Teams running frequent, small-batch antibody libraries usually find the instrument model cheaper once monthly volume exceeds a few dozen constructs.

Yes, but turnaround times lengthen from days to one-to-two weeks and you lose the ability to iterate sequences the same day. Many groups keep a BioXp for urgent work and outsource only large, routine orders to IDT or GenScript.

Any on-premise system such as the BioXp or emerging microfluidic synthesizers keeps sequences inside your firewall. Outsourced providers like Eurofins or Thermo Fisher require sequence upload and therefore reduce IP isolation.

Academic groups sometimes build custom microfluidic synthesizers or use Gibson Assembly with manual pipetting, but none match the walk-away automation and error-correction of the BioXp. Most labs therefore treat the BioXp as a capital purchase rather than a software subscription.

Evaluate sequence length limits, turnaround variability, biosecurity review processes, and total cost including shipping and customs. Cloud services excel at very large libraries; Codex DNA-style hardware remains preferable for rapid, iterative therapeutic design cycles.